CHEK Check-Cap upside potential - huge volume!

Check-Cap Ltd. is a clinical stage medical diagnostics company engaging in the development of ingestible imaging capsule system for colorectal cancer screening.
Net Income $-13,840,000, but an encouraging Quick Ratio of 3.69.
Looking at the volume, this asset can double its price is seconds.
on 5/28/2020 HC Wainwright Reiterated Chek Rating to Buy and the target is $2.00.
Not trading advice.

If you are interested to test some amazing buy and sell indicators, which give the signal at the beginning of the candle, not at the end of it, just leave me a message.